Table 1.
UK surveillance studies on COVID-19 in pregnant women and their babies
| Name of study | Institution | Inclusion | Reporting by | Consent required | Likely coverage in Scotland |
| COVID-19 in Pregnancy47 | UK Obstetric Surveillance System study | Any women admitted to hospital in the UK with confirmed COVID-19 at any stage of pregnancy | Front-line clinicians | No | High |
| Pregnancy And Neonatal outcomes for women with COVID-1948 | National Institute of Healthcare Research Imperial Biomedical Research Centre | Women who have suspected or confirmed COVID-19 at any stage during pregnancy and their babies | Front-line clinicians | Yes | Unknown as yet |
| Clinical Characterisation Protocol Tier 0 study17 | The International Severe Acute Respiratory and emerging Infection Consortium | Any patient admitted participating hospitals in the UK with confirmed COVID-19 | Reporting is by research nurses | No | Low but may increase |
| Neonatal complications of COVID-1917 | British Paediatric Surveillance Unit |
All babies born to mothers with COVID-19 who are admitted to neonatal care (whether the baby has COVID-19 or not) and all babies with confirmed COVID-19 in the neonatal period. | Front-line clinicians. | No | High |
| Multisystem inflammatory syndrome, Kawasaki disease and toxic shock syndrome15 | British Paediatric Surveillance Unit | All children less than 16 years old (including neonates) with multisystem inflammatory syndrome due to SARS-CoV-2 infection or otherwise unexplained. | Front-line clinicians | No | High |
| Understanding COVID-19 infection in women and their babies (periCOVID)49 | Public Health England and St George’s University London | Any pregnant woman with confirmed COVID-19 infection from 24 weeks gestation in England | Clinicians/research midwives and nurses | Yes | None |